Long-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and good tolerability for up to 3 years in patients with ...
Callum Hobson suffered Topical Steroid Withdrawal (TSW), also known as Red Skin Syndrome (RSS), when he stopped using the cream which resulted in the skin all over his body becoming severely inflamed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results